We are live on ! Find out more
MLAB icon

Mesa Laboratories

93 hedge funds and large institutions have $338M invested in Mesa Laboratories in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 45 increasing their positions, 29 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 29

2.03% more ownership

Funds ownership: 69.91%71.93% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less funds holding

Funds holding: 10193 (-8)

14% less capital invested

Capital invested by funds: $394M → $338M (-$55.5M)

57% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 14

Holders
93
Holders Change
-8
Holders Change %
-7.92%
% of All Funds
2.11%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
45
Reduced
29
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CCA
1
Conestoga Capital Advisors
Pennsylvania
$52.7M +$7.07M +50,577 +14%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$33.9M -$89.1K -637 -0.2%
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$22.3M -$429K -3,066 -2%
BlackRock
4
BlackRock
New York
$21.8M +$423K +3,025 +2%
Victory Capital Management
5
Victory Capital Management
Texas
$21.5M +$3.54M +25,306 +17%
Vanguard Group
6
Vanguard Group
Pennsylvania
$19.3M +$592K +4,232 +3%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$16.7M +$768K +5,495 +4%
NTCM
8
Nine Ten Capital Management
Illinois
$11.5M -$4.15M -29,658 -24%
TAM
9
THB Asset Management
Connecticut
$11M +$1.56M +11,164 +14%
Kayne Anderson Rudnick Investment Management
10
Kayne Anderson Rudnick Investment Management
California
$10.8M +$1.51M +10,822 +14%
RA
11
Royce & Associates
New York
$9.79M +$320K +2,289 +3%
Renaissance Technologies
12
Renaissance Technologies
New York
$9.77M -$783K -5,600 -7%
State Street
13
State Street
Massachusetts
$7.34M +$320K +2,291 +4%
ACH
14
ArrowMark Colorado Holdings
Colorado
$7.24M +$488K +3,486 +6%
PM
15
Pembroke Management
Quebec, Canada
$6.67M -$420K -3,000 -5%
Luther King Capital Management (LKCM)
16
Luther King Capital Management (LKCM)
Texas
$6.01M +$2.5M +17,880 +59%
Northern Trust
17
Northern Trust
Illinois
$5.62M -$32.4K -232 -0.5%
Ameriprise
18
Ameriprise
Minnesota
$5.34M +$699K +5,000 +13%
TA
19
Teton Advisors
New York
$4.2M -$69.9K -500 -1%
WA
20
Wasatch Advisors
Utah
$3.62M -$755K -5,402 -16%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$3.56M +$10.8K +77 +0.3%
CIC
22
Crawford Investment Counsel
Georgia
$3.44M +$540K +3,864 +16%
Lord, Abbett & Co
23
Lord, Abbett & Co
New Jersey
$2.91M -$841K -6,012 -20%
Allianz Asset Management
24
Allianz Asset Management
Germany
$2.84M -$52.7K -377 -2%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$2.14M -$74K -529 -3%

MLAB Hedge Fund Activity: Q4 2017 in Review

93 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2017, worth a combined $338M — down 14% from $394M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of MLAB and 6 opened new positions — a net loss of 8 holders — while 29 trimmed existing stakes and 45 added.

The largest buyer was Conestoga Capital Advisors, adding an estimated $7.07M. The largest seller was Nine Ten Capital Management, cutting an estimated $4.15M.

  • 93 institutional investors held Mesa Laboratories (MLAB) as of Q4 2017, down from 101 in Q3 2017.
  • Funds reported $338M of Mesa Laboratories stock for Q4 2017, down 14% quarter-over-quarter.
  • 6 funds opened new Mesa Laboratories positions in Q4 2017 and 14 closed out, a net change of -8 holders.
  • The largest Mesa Laboratories buyer in Q4 2017 was Conestoga Capital Advisors, an estimated $7.07M added.
  • The largest Mesa Laboratories seller in Q4 2017 was Nine Ten Capital Management, an estimated $4.15M sold.

Based on aggregated 13F filings for Q4 2017.